Unbiased Analysis of Today's Healthcare Issues

The Cost of Adherence Mismeasurement: A Claims-Based Analysis

If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “The Cost of Adherence Mismeasurement: A Claims-Based Analysis” co-authored with Felicia Forma, Ethan Scherer, Ainslie Hatch and Darius Lakdawalla.  The presentation abstract is below and here. BACKGROUND: Payers often wish to measure how adherence to prescription drugs affects downstream […]

Read the rest of this entry »

AMCP Nexus Poster: Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia

If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia” co-authored with Joanna MacEwan, Felicia Forma, Ainslie Hatch and Darius Lakdawalla.  The presentation abstract is below and here.   BACKGROUND: Many payers rely on claims-based metrics—such as those […]

Read the rest of this entry »

Patient adherence to antipsychotic medications

Patients with schizophrenia often require medication—such as antipsychotics—to control the symptoms of their disease. However, adherence to these medications has been poor. Valenstein et al. (2004) estimate that 40% of patients are non-compliant with therapy [i.e., mediation possession ratio (MPR)<0.8]. Why are schizophrenia patients likely to be non-complient to antipsychotic therapy? One key reason is […]

Read the rest of this entry »